BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28705793)

  • 1. Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report.
    Pujol F; Hodgson T; Martinez-Corral I; Prats AC; Devenport D; Takeichi M; Genot E; Mäkinen T; Francis-West P; Garmy-Susini B; Tatin F
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1732-1735. PubMed ID: 28705793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow.
    Betterman KL; Sutton DL; Secker GA; Kazenwadel J; Oszmiana A; Lim L; Miura N; Sorokin L; Hogan BM; Kahn ML; McNeill H; Harvey NL
    J Clin Invest; 2020 Jun; 130(6):3315-3328. PubMed ID: 32182215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain.
    Roukens MG; Peterson-Maduro J; Padberg Y; Jeltsch M; Leppänen VM; Bos FL; Alitalo K; Schulte-Merker S; Schulte D
    Circ Res; 2015 May; 116(10):1660-9. PubMed ID: 25814692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome.
    Alders M; Al-Gazali L; Cordeiro I; Dallapiccola B; Garavelli L; Tuysuz B; Salehi F; Haagmans MA; Mook OR; Majoie CB; Mannens MM; Hennekam RC
    Hum Genet; 2014 Sep; 133(9):1161-7. PubMed ID: 24913602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic mutation of FBXL7 suggests a novel form of Hennekam syndrome.
    Boone PM; Paterson S; Mohajeri K; Zhu W; Genetti CA; Tai DJC; Nori N; Agrawal PB; Bacino CA; Bi W; Talkowski ME; Hogan BM; Rodan LH
    Am J Med Genet A; 2020 Jan; 182(1):189-194. PubMed ID: 31633297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenomedullin signaling is necessary for murine lymphatic vascular development.
    Fritz-Six KL; Dunworth WP; Li M; Caron KM
    J Clin Invest; 2008 Jan; 118(1):40-50. PubMed ID: 18097475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation.
    Nonomura K; Lukacs V; Sweet DT; Goddard LM; Kanie A; Whitwam T; Ranade SS; Fujimori T; Kahn ML; Patapoutian A
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12817-12822. PubMed ID: 30482854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ADAMTS3 activity causes Hennekam lymphangiectasia-lymphedema syndrome 3.
    Brouillard P; Dupont L; Helaers R; Coulie R; Tiller GE; Peeden J; Colige A; Vikkula M
    Hum Mol Genet; 2017 Nov; 26(21):4095-4104. PubMed ID: 28985353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digging deeper into lymphatic vessel formation in vitro and in vivo.
    Detry B; Bruyère F; Erpicum C; Paupert J; Lamaye F; Maillard C; Lenoir B; Foidart JM; Thiry M; Noël A
    BMC Cell Biol; 2011 Jun; 12():29. PubMed ID: 21702933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology and pathology of lymphangiogenesis.
    Karpanen T; Alitalo K
    Annu Rev Pathol; 2008; 3():367-97. PubMed ID: 18039141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonvenous origin of dermal lymphatic vasculature.
    Martinez-Corral I; Ulvmar MH; Stanczuk L; Tatin F; Kizhatil K; John SW; Alitalo K; Ortega S; Makinen T
    Circ Res; 2015 May; 116(10):1649-54. PubMed ID: 25737499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.
    Bos FL; Caunt M; Peterson-Maduro J; Planas-Paz L; Kowalski J; Karpanen T; van Impel A; Tong R; Ernst JA; Korving J; van Es JH; Lammert E; Duckers HJ; Schulte-Merker S
    Circ Res; 2011 Aug; 109(5):486-91. PubMed ID: 21778431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and immunofluorescence expression profile of lymphatic endothelial cell markers in oral cancer.
    Chutipongpisit K; Parachuru VP; Friedlander LT; Hussaini HM; Rich AM
    Int J Exp Pathol; 2021 Dec; 102(6):268-278. PubMed ID: 34791715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic vessel function in head and neck inflammation.
    Truman LA; A-Gonzalez N; Bentley KL; Ruddle NH
    Lymphat Res Biol; 2013 Sep; 11(3):187-92. PubMed ID: 24044758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sox18 induces development of the lymphatic vasculature in mice.
    François M; Caprini A; Hosking B; Orsenigo F; Wilhelm D; Browne C; Paavonen K; Karnezis T; Shayan R; Downes M; Davidson T; Tutt D; Cheah KS; Stacker SA; Muscat GE; Achen MG; Dejana E; Koopman P
    Nature; 2008 Dec; 456(7222):643-7. PubMed ID: 18931657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration.
    Choi I; Lee YS; Chung HK; Choi D; Ecoiffier T; Lee HN; Kim KE; Lee S; Park EK; Maeng YS; Kim NY; Ladner RD; Petasis NA; Koh CJ; Chen L; Lenz HJ; Hong YK
    Angiogenesis; 2013 Jan; 16(1):29-44. PubMed ID: 22945845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP and TAZ maintain PROX1 expression in the developing lymphatic and lymphovenous valves in response to VEGF-C signaling.
    Cha B; Ho YC; Geng X; Mahamud MR; Chen L; Kim Y; Choi D; Kim TH; Randolph GJ; Cao X; Chen H; Srinivasan RS
    Development; 2020 Dec; 147(23):. PubMed ID: 33060128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
    Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
    Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.